MALDI-TOF MS data analysis

AG Anna E. Gauthier
CC Courtney E. Chandler
VP Valentina Poli
FG Francesca M. Gardner
AT Aranteiti Tekiau
RS Richard Smith
KB Kevin S. Bonham
EC Erik E. Cordes
TS Timothy M. Shank
IZ Ivan Zanoni
DG David R. Goodlett
SB Steven J. Biller
RE Robert K. Ernst
RR Randi D. Rotjan
JK Jonathan C. Kagan
request Request a Protocol
ask Ask a question
Favorite

Replicate m/z spectra data were generated for each lipid A. Bruker Daltonics flexAnalysis software was used to analyze all spectral data generated. Lipid A was classified as hexa- or hepta-acylated based on the m/z ratio of its primary spectral peak. On the basis of previous MS-based studies on LPS lipid A (35, 5355), peaks with m/z ratios between 1650 and 1800 amu are predicted to be hexa-acylated, whereas peaks above 2000 amu are predicted to be hepta-acylated. Using these parameters, the acyl chain number present in lipid A of each strain was predicted. In addition, the loss or addition of a phosphate to the diglucosamine backbone was indicated by an m/z change of 80 amu, and the addition of PEtn was indicated by an m/z change of 123 amu. The presence of the outer membrane molecule, cardiolipin, was indicated by an m/z ratio value of 1456 amu and single carbon loss/additions.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A